Table 3.

Response details in patients evaluable by irRC

Patient ID	Total lesions (n)	Lesion(s) injected (n)/type of lesion injected	Presence of visceral lesion(s)	Response in injected lesion(s)/path	Response in non-injected lesions/path/lesion type
8	4	3/palpable lymph nodes	No	irPR	irPR/path not assessed/regional dermal metastases
9	>10	3/subcutaneous in-transit metastases	No	irPR/pCR	irPR/pCR/subcutaneous in-transit metastases
11	2	1*/palpable lymph node	No	irPR	irPR/path not assessed/regional dermal metastasis
12	>10	1*/subcutaneous in-transit metastasis	No	irSD/pCR	irSD/pCR/subcutaneous in-transit metastases

*3 injections into the same lesion.

irPR, immune-related response criteria-confirmed partial response; irRC, immune-related response criteria; irSD, immune-related response criteria-confirmed stable disease; path, pathological evaluation; pCR, pathological complete response.